GlobalData Market Research Reports





RSS Sort By :
TITLE Price Buy Now More options

There are no long-term effective therapies for Alzheimer's Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies are relatively safe and effective, these therapies are still lac...

$ 10995


MediPoint: Hernia Repair - Global Analysis and Market Forecasts Summary Dramatic improvements in access to and quality of healthcare in the Asia Pacific region, concurrent with the introduction of next-generation biologic and composite meshes i

$ 6495


MediPoint: Total Hip Replacement - Global Analysis and Market Forecasts Summary Osteoarthritis has become a global public health concern with no cure. It is the most common form of arthritis that is primarily due to wear and tear of the joints.

$ 6495


PharmaPoint: Postmenopausal Vaginal Atrophy - Japan Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it is expected to undergo a consi

$ 4995


PharmaPoint: Type 2 Diabetes - US Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - US Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market is mat

$ 4995


PharmaPoint: Type 2 Diabetes - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - France Drug Forecast and Market Analysis to 2022”. The type 2 diabetes marke

$ 4995


PharmaPoint: Type 2 Diabetes - Germany Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - Germany Drug Forecast and Market Analysis to 2022”. The type 2 diabetes mar

$ 4995


PharmaPoint: Type 2 Diabetes - Italy Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - Italy Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market

$ 4995


PharmaPoint: Type 2 Diabetes - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - Spain Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market

$ 4995


PharmaPoint: Type 2 Diabetes - UK Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - UK Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market is mat

$ 4995


PharmaPoint: Type 2 Diabetes - Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - Japan Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market

$ 4995


PharmaPoint: Type 2 Diabetes - China Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - China Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market

$ 4995


PharmaPoint: Type 2 Diabetes - India Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - India Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market

$ 4995


PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022”. The type 2 diabetes marke

$ 4995


PharmaPoint: Postmenopausal Vaginal Atrophy - US Drug Forecast And Market Analysis To 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it is expected to undergo a consider

$ 4995


PharmaPoint: Postmenopausal Vaginal Atrophy - France Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it is expected to undergo a cons

$ 4995


PharmaPoint: Postmenopausal Vaginal Atrophy - Germany Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it is expected to undergo a con

$ 4995


PharmaPoint: Postmenopausal Vaginal Atrophy - Italy Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it is expected to undergo a consi

$ 4995


PharmaPoint: Postmenopausal Vaginal Atrophy - Spain Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it is expected to undergo a consi

$ 4995


PharmaPoint: Postmenopausal Vaginal Atrophy - UK Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it is expected to undergo a consider

$ 4995

Live Chat Support
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest from GlobalData. We have market research reports of all sectors covered by the GlobalData; you can access and utilize them at economical budgets.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100